Cybin (HELP) Depreciation & Amortization - Total (2021 - 2024)
Cybin (HELP) reported Depreciation & Amortization - Total of $132432.1 for Q4 2024, down 39.9% on a YoY basis from $220360.7 in Q1 2024, and down 16.36% quarter-over-quarter from $158339.5 in Q3 2024.
Cybin (HELP) Depreciation & Amortization - Total (2021 - 2024) Analysis & Trends
Cybin has reported Depreciation & Amortization - Total for 4 years, with the latest figure at $132432.1 in Q4 2024.
- For the quarter ending Q4 2024, Depreciation & Amortization - Total fell 39.9% year-over-year to $132432.1; the trailing twelve-month figure through Dec 2024 stood at $132432.1 (down 39.9% YoY), and the FY2024 full-year result was $197402.1, changed N/A from the prior year.
- Depreciation & Amortization - Total for Q4 2024 stood at $132432.1, down from $158339.5 in the prior quarter.
- The five-year high for Depreciation & Amortization - Total was $456388.7 in Q2 2021, with the low at $132432.1 in Q4 2024.
- Historically, Depreciation & Amortization - Total has averaged $308658.6 across 4 years, with a median of $325325.7 in 2023.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization - Total retreated 1.21% — and 2024, when it slumped 48.98%.
- Cybin's Depreciation & Amortization - Total stood at $418881.5 in 2021, then dropped by 11.18% to $372035.0 in 2022, then slumped by 40.77% to $220360.7 in 2023, then slumped by 39.9% to $132432.1 in 2024.
- The last three Depreciation & Amortization - Total figures came in at $132432.1 (Q4 2024), $158339.5 (Q3 2024), and $165968.9 (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 132,432.09 |
| Sep 30, 2024 | 158,339.54 |
| Jun 30, 2024 | 165,968.90 |
| Mar 31, 2024 | 197,402.11 |
| Dec 31, 2023 | 220,360.66 |
| Sep 30, 2023 | 253,616.36 |
| Jun 30, 2023 | 325,325.73 |
| Dec 31, 2022 | 372,034.98 |
| Sep 30, 2022 | 433,211.63 |
| Dec 31, 2021 | 418,881.45 |
| Sep 30, 2021 | 438,513.94 |
| Jun 30, 2021 | 456,388.74 |
| Mar 31, 2021 | 440,085.21 |